Evidence map›Paper›PMID 30947807›Full record

ArticleeLife2019

Optogenetic control shows that kinetic proofreading regulates the activity of the T cell receptor.

O Sascha Yousefi, Matthias Günther, Maximilian Hörner, Julia Chalupsky, Maximilian Wess, Simon M Brandl, Robert W Smith, Christian Fleck, Tim Kunkel, Matias D Zurbriggen and 3 more

Abstract read
In one paragraph

Article in eLife, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Coupling Recombinant PhyB to Cell Culture Plates and Beads.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Parallel reactions on a single T cell receptor offer a robust kinetic proofreading mechanism.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  12. Optogenetic engineering for precision cancer immunotherapy.Trends in pharmacological sciences · 2025
    Review
  13. Review
  14. Proofreading and single-molecule sensitivity in T cell receptor signaling by condensate nucleation.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Physical extraction of antigen and information.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

O Sascha YousefiSignalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.ORCID 0000-0001-5304-729X
Matthias GüntherDivision of Theoretical Systems Biology, German Cancer Research Center, Heidelberg, Germany.ORCID 0000-0001-8077-8194
Maximilian HörnerSignalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.ORCID 0000-0003-1743-9581
Julia ChalupskySignalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.
Maximilian WessSignalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.
Simon M BrandlSignalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.
Robert W SmithLaboratory of Systems and Synthetic Biology, Wageningen University and Research, Wageningen, Netherlands.ORCID 0000-0001-9657-7477
Christian FleckLaboratory of Systems and Synthetic Biology, Wageningen University and Research, Wageningen, Netherlands.
Tim KunkelFaculty of Biology, University of Freiburg, Freiburg, Germany.
Matias D ZurbriggenSignalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.
Thomas HöferDivision of Theoretical Systems Biology, German Cancer Research Center, Heidelberg, Germany.
Wilfried WeberSignalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.
Wolfgang Wa SchamelSignalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.ORCID 0000-0003-4496-3100

Funding

Deutsche Forschungsgemeinschaft EXC2189Deutsche Forschungsgemeinschaft EXC294Deutsche Forschungsgemeinschaft EXC81Deutsche Forschungsgemeinschaft GSC-4Deutsche Forschungsgemeinschaft INST 39/899-1 FUGG
6 · The paper itself

Abstract

The immune system distinguishes between self and foreign antigens. The kinetic proofreading (KPR) model proposes that T cells discriminate self from foreign ligands by the different ligand binding half-lives to the T cell receptor (TCR). It is challenging to test KPR as the available experimental systems fall short of only altering the binding half-lives and keeping other parameters of the interaction unchanged. We engineered an optogenetic system using the plant photoreceptor phytochrome B (PhyB) as a ligand to selectively control the dynamics of ligand binding to the TCR by light. This opto-ligand-TCR system was combined with the unique property of PhyB to continuously cycle between the binding and non-binding states under red light, with the light intensity determining the cycling rate and thus the binding duration. Mathematical modeling of our experimental datasets showed that indeed the ligand-TCR interaction half-life is the decisive factor for activating downstream TCR signaling, substantiating KPR.

Indexed as

Signal TransductionAntigensHumansJurkat CellsKineticsLightModels, TheoreticalOptogeneticsPhytochrome BProtein BindingReceptors, Antigen, T-CellT-LymphocytesAntigensPhytochrome BReceptors, Antigen, T-CellA. thalianadynamicshumanimmunologyinflammationligand-receptoroptogeneticssignalingT cells

Identifiers

PMID30947807
PMCPMC6488296

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.